Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-09

Clinical Trial Update: Effect of Ferric Sulphate and Putty MTA as Pulpotomy Agent in Vital Primary Teeth [NA]

View source ↗

Summary

A clinical trial is evaluating ferric sulphate and putty MTA as pulpotomy agents in vital primary teeth and is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ferric Sulphate (ferric sulfate)
  • Putty MTA (mineral trioxide aggregate putty)

Snippet

Sponsor: University of Jazan | Conditions: Pulptomy, Dental Caries | NA | Status: ENROLLING_BY_INVITATION